Phase 1/2 StudiesIdentify biomarkers of response and resistance to guide your Phase 3 strategy
Biomarkers of response
Identify baseline and early on-treatment biomarkers of response and resistance
Timing and dosing
Optimize your timing and dosing strategy at the cellular level by profiling immune activation at critical timepoints
Refine patient selection for future trials by enrolling patients based on their unique immune fingerprint
Identify immune biomarkers of response in peripheral blood
Profile major and minor immune cell subsets across cell states of activation, exhaustion, and senescence all in a single panel. Never miss a crucial cell subset again.
Optimize clinical dosing strategies
Immune monitoring can increase dosing accuracy by measuring immune activation at the cellular level. Optimize timing and dosing strategies via longitudinal blood-based monitoring to maximize and sustain treatment response.
Let data drive your patient selection
Enroll patients based on their unique immune fingerprint. Baseline biomarkers of response can refine patient selection for future trials and route patients to successful therapies.